Profile
Carl Magnus Högerkorp is the founder of Immodulate Pharma AB, which was founded in 2021.
He held the title of Chief Executive Officer at Immodulate Pharma AB.
Dr. Högerkorp also held the position of Chief Executive Officer at CanImGuide Therapeutics AB from 2019 to 2021, at Edvince AB from 2017 to 2018, and at Xintela AB from 2016 to 2017.
He was also the Chief Executive Officer at Cyxone AB from 2022 to 2023.
Dr. Högerkorp obtained a doctorate degree from the University of Lund and an MBA from Lund University School of Economics & Management.
Former positions of Carl Magnus Högerkorp
| Companies | Position | End |
|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Chief Executive Officer | 01/04/2021 |
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Chief Executive Officer | 01/10/2018 |
| XINTELA AB | Chief Tech/Sci/R&D Officer | 01/04/2017 |
| Immodulate Pharma AB | Chief Executive Officer | - |
| CYXONE AB | Chief Executive Officer | - |
Training of Carl Magnus Högerkorp
| University of Lund | Doctorate Degree |
| Lund University School of Economics & Management | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| XINTELA AB | Health Technology |
| CYXONE AB | Health Technology |
| Private companies | 3 |
|---|---|
Edvince AB
Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Health Technology |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
| Immodulate Pharma AB |
- Stock Market
- Insiders
- Carl Magnus Högerkorp
